Results 81 to 90 of about 74,782 (138)

Aspergillus Serology Predicts Relapse in Chronic Pulmonary Aspergillosis: Implications for Personalised Follow‐Up Strategies

Mycoses, Volume 69, Issue 2, February 2026.
ABSTRACT Introduction Relapses occur in up to 40% of patients after prolonged courses of antifungal treatment for chronic pulmonary aspergillosis (CPA). The factors predisposing to relapse remain poorly defined. Methods We conducted a retrospective study of adults treated for ≥ 6 months with oral azoles for CPA.
Annabel Choyce, Stefano Colombo, Cyrin Cyriac, Abdulrazaq Alasfour, Wai Kien Ng, Lauren Amphlett, Chris Kosmidis   +6 more
wiley   +1 more source

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: 12 months results [PDF]

, 2017
Background: Biological agents, such as infliximab, have transformed the outcomes of patients with immune-mediated inflammatory diseases. The advent of biosimilar treatment options such as CT-P13 promises to improve the availability of biological therapy,
Argüelles Arias, Federico, Castro Laria, Luisa, Guerra Veloz, María Fernanda, Maldonado Pérez, Belén, Merino Bohórquez, Vicente, Perea Amarillo, Raúl, Romero Gómez, Manuel, Vilches Arenas, Ángel   +7 more
core  

A Review of the Molecular and Genetic Foundations of Ankylosing Spondylitis [PDF]

, 2012
Ankylosing Spondylitis (AS) is an autoimmune disease that occurs in an adult-onset or juvenile-onset form. The symptoms, severity, and prevalence of this disease vary according to sex, age, and race.
Dowlearn, Emily
core  

The cataract response in Radium-224 patients [PDF]

, 1989
Chmelevsky, D., Kellerer, Albrecht M., Mays, C. W., Spiess, H., Stefani, F.-H., Taylor, David M.   +5 more
core   +1 more source

The causal relationship between cathepsins and ankylosing spondylitis: a two-sample Mendelian randomization study. [PDF]

Ther Adv Musculoskelet Dis
Wu B, Li R, Li J, An Q, Jin S, Liu Q, Zhang Y, Liu Y.   +7 more
europepmc   +1 more source

Correlation Between Serum Procalcitonin and Disease Activity Score in Patients with Ankylosing Spondylitis That Have Hip Involvement. [PDF]

Int J Gen Med
Liang X, Deng B.
europepmc   +1 more source

Patient-tailored training programme on cardiorespiratory fitness, trunk strength and mobility leads to significantly better outcomes in individuals with axial spondyloarthritis. [PDF]

RMD Open
De Mits S, Willems T, Calders P, Danneels L, Varkas G, Van den Bosch F, Elewaut D, Carron P.   +7 more
europepmc   +1 more source

Comparison of radiographic spinal changes and their progression in patients with axial spondyloarthritis vs. psoriatic arthritis with inflammatory axial involvement. [PDF]

Arthritis Res Ther
Sewerin P, Redeker I, Lavda E, Supp G, Sieghart D, Aletaha D, Mandl P, Kiefer D, Baraliakos X.   +8 more
europepmc   +1 more source

Alterations in the Gut Microbiome in Ankylosing Spondylitis and Their Correlation with Disease Activity. [PDF]

J Microbiol Biotechnol
Jeong H, Seo H, Kim S, Rahim MA, Barman I, Shuvo MSH, Jo S, Hossain MS, Yoo JJ, Kim YH, Jung SS, Song HY, Jeon CH.   +12 more
europepmc   +1 more source

Factors affecting employment in Japanese patients with ankylosing spondylitis (AS). [PDF]

BMC Rheumatol
Furusawa H, Tada K, Hayashi E, Inoue H, Kobayashi S, Yamaji K, Tamura N.   +6 more
europepmc   +1 more source